Publications

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism

Authors: AM Vaquié, DR Shah, EES Brechbühl, M McNicholas, Z Xu, JH Stockley, L Mor...

Research group: Brindle Group

E-pub date: 1 Feb 2026

Journal name: Mol Oncol

Optical coherence tomography and elastography for ex vivo visualization of early gastric cancer.

Authors: AG Gonzales, C Ruhland, G Spicer, S Mead, M Di Pietro, A Sanduka, PFS Rice,...

Research group: Bohndiek Group

E-pub date: 1 Feb 2026

Journal name: J Biomed Opt

Loss of CTLH component MAEA impairs DNA repair and replication and leads to developmental delay.

Authors: SH Hough, SS Jhujh, SW Awwad, OE Lewis, S Lam, JC Thomas, T Mosler, A Bader...

Research group: Jackson Group

E-pub date: 1 Feb 2026

Journal name: EMBO Mol Med

MDC1 counteracts replication fork reversal and mediates chemosensitivity in BRCA1/2-deficient tumors.

Authors: H Dogan, M Liptay, JS Barbosa, E Gogola, AA Duarte, JA Schmid, I Klebic, M ...

Research group: Jackson Group

E-pub date: 1 Feb 2026

Journal name: Oncogene

5-methylcytosine and 5-hydroxymethylcytosine are synergistic biomarkers for early detection of colorectal cancer.

Authors: F Puddu, A Johansson, A Modat, J Scotcher, R Sethi, S Yu, N Harding, M Hill...

Research group: Balasubramanian Group

E-pub date: 20 Jan 2026

Journal name: Commun Med (Lond)

CRISPR screens in the context of immune selection identify CHD1 and MAP3K7 as mediators of cancer immunotherapy resistance.

Authors: A Watterson, G Picco, V Veninga, Y Samarakoon, CM Cattaneo, SF Vieira, E Ka...

Research group: Halim Group

E-pub date: 20 Jan 2026

Journal name: Cell Rep Med

Developing Predictive and Robust Radiomics Models for Chemotherapy Response in High-Grade Serous Ovarian Carcinoma

Authors: S Hatamikia, G George, F Schwarzhans, A Mahbod, MA Reinius, AA Ardakani, M ...

Research group: Brenton Group

E-pub date: 13 Jan 2026

Journal name:

Lung Metastases in Pancreatic Cancer: Timing Their First Breath.

Authors: G Mucciolo, G Biffi

Research group: Biffi Group

E-pub date: 2 Jan 2026

Journal name: Cancer Res

Filters

Research Groups

Core Facilities

Start date

End date

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism

Optical coherence tomography and elastography for ex vivo visualization of early gastric cancer.

Loss of CTLH component MAEA impairs DNA repair and replication and leads to developmental delay.

MDC1 counteracts replication fork reversal and mediates chemosensitivity in BRCA1/2-deficient tumors.

5-methylcytosine and 5-hydroxymethylcytosine are synergistic biomarkers for early detection of colorectal cancer.

CRISPR screens in the context of immune selection identify CHD1 and MAP3K7 as mediators of cancer immunotherapy resistance.

Developing Predictive and Robust Radiomics Models for Chemotherapy Response in High-Grade Serous Ovarian Carcinoma

Lung Metastases in Pancreatic Cancer: Timing Their First Breath.

Themes

Filters

Research Groups

Core Facilities

Start date

End date

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism

Optical coherence tomography and elastography for ex vivo visualization of early gastric cancer.

Loss of CTLH component MAEA impairs DNA repair and replication and leads to developmental delay.

MDC1 counteracts replication fork reversal and mediates chemosensitivity in BRCA1/2-deficient tumors.

5-methylcytosine and 5-hydroxymethylcytosine are synergistic biomarkers for early detection of colorectal cancer.

CRISPR screens in the context of immune selection identify CHD1 and MAP3K7 as mediators of cancer immunotherapy resistance.

Developing Predictive and Robust Radiomics Models for Chemotherapy Response in High-Grade Serous Ovarian Carcinoma

Lung Metastases in Pancreatic Cancer: Timing Their First Breath.